Quarterly report pursuant to Section 13 or 15(d)

CONDENSED BALANCE SHEETS

v3.20.1
CONDENSED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 8,038 $ 5,223
Receivables 1,551 993
Inventory 1,064 998
Prepaid expenses and other current assets 1,493 1,094
Total current assets 12,146 8,308
Property and equipment, net 780 817
Operating lease right-of-use asset 336 397
Total assets 13,262 9,522
Current liabilities:    
Accounts payable 1,332 1,401
Accrued clinical trials expenses 440 309
Accrued sales allowances 201 809
Other accrued liabilities 1,488 809
Operating lease liability, current 282 272
Current portion of long-term debt 667 0
Total current liabilities 4,410 3,600
Operating lease liability, non-current 76 150
Long-term debt 3,500 4,019
Warrant liability 0 320
Total liabilities 7,986 8,089
Stockholders' equity:    
Common stock, at amounts paid-in 93 57
Additional paid-in capital 359,804 350,413
Accumulated deficit (354,621) (349,037)
Total stockholders' equity 5,276 1,433
Total liabilities and stockholders' equity $ 13,262 $ 9,522